A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus - Infected women reporting protease inhibitor use

K. T. Tashima, J. W. Hogan, L. I. Gardner, C. Korkontzelou, Ellie Schoenbaum, P. Schuman, A. Rompalo, C. C J Carpenter

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The impact of protease inhibitors (PIs) on emergency department (i.e., emergency room [ER]) visits and hospitalizations was examined among a cohort of human immunodeficiency virus (HIV)-infected and high-risk women followed-up in the HIV Epidemiology Research Study (HERS) from 1993 through 1999. The rates of hospitalization and ER visits were measured as a function of recent or current PI use, age, race, transmission risk category, HERS site, baseline CD4 cell count, and baseline virus load; the PI effect was estimated separately by baseline CD4 cell count. In the HERS, PI use was strongly associated with lower rates of ER visits and hospitalizations for patients with baseline CD4 cell counts of <200 cells/mL (for hospitalizations: Rate ratio [RR], 0.54; 95% confidence interval [CI], 0.33-0.89; for ER visits: RR, 0.38; 95% CI, 0.24-0.61). Other factors associated with increased hospitalization and ER use included history of injection drug use, low CD4 cell counts, and high virus loads.

Original languageEnglish (US)
Pages (from-to)2055-2060
Number of pages6
JournalClinical Infectious Diseases
Volume33
Issue number12
DOIs
StatePublished - Dec 15 2001

Fingerprint

Protease Inhibitors
Hospital Emergency Service
Hospitalization
HIV
CD4 Lymphocyte Count
Epidemiology
Research
Confidence Intervals
Viruses
Injections
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology

Cite this

A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus - Infected women reporting protease inhibitor use. / Tashima, K. T.; Hogan, J. W.; Gardner, L. I.; Korkontzelou, C.; Schoenbaum, Ellie; Schuman, P.; Rompalo, A.; Carpenter, C. C J.

In: Clinical Infectious Diseases, Vol. 33, No. 12, 15.12.2001, p. 2055-2060.

Research output: Contribution to journalArticle

Tashima, K. T. ; Hogan, J. W. ; Gardner, L. I. ; Korkontzelou, C. ; Schoenbaum, Ellie ; Schuman, P. ; Rompalo, A. ; Carpenter, C. C J. / A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus - Infected women reporting protease inhibitor use. In: Clinical Infectious Diseases. 2001 ; Vol. 33, No. 12. pp. 2055-2060.
@article{2543a04154054877b1c00e92429a4749,
title = "A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus - Infected women reporting protease inhibitor use",
abstract = "The impact of protease inhibitors (PIs) on emergency department (i.e., emergency room [ER]) visits and hospitalizations was examined among a cohort of human immunodeficiency virus (HIV)-infected and high-risk women followed-up in the HIV Epidemiology Research Study (HERS) from 1993 through 1999. The rates of hospitalization and ER visits were measured as a function of recent or current PI use, age, race, transmission risk category, HERS site, baseline CD4 cell count, and baseline virus load; the PI effect was estimated separately by baseline CD4 cell count. In the HERS, PI use was strongly associated with lower rates of ER visits and hospitalizations for patients with baseline CD4 cell counts of <200 cells/mL (for hospitalizations: Rate ratio [RR], 0.54; 95{\%} confidence interval [CI], 0.33-0.89; for ER visits: RR, 0.38; 95{\%} CI, 0.24-0.61). Other factors associated with increased hospitalization and ER use included history of injection drug use, low CD4 cell counts, and high virus loads.",
author = "Tashima, {K. T.} and Hogan, {J. W.} and Gardner, {L. I.} and C. Korkontzelou and Ellie Schoenbaum and P. Schuman and A. Rompalo and Carpenter, {C. C J}",
year = "2001",
month = "12",
day = "15",
doi = "10.1086/323978",
language = "English (US)",
volume = "33",
pages = "2055--2060",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus - Infected women reporting protease inhibitor use

AU - Tashima, K. T.

AU - Hogan, J. W.

AU - Gardner, L. I.

AU - Korkontzelou, C.

AU - Schoenbaum, Ellie

AU - Schuman, P.

AU - Rompalo, A.

AU - Carpenter, C. C J

PY - 2001/12/15

Y1 - 2001/12/15

N2 - The impact of protease inhibitors (PIs) on emergency department (i.e., emergency room [ER]) visits and hospitalizations was examined among a cohort of human immunodeficiency virus (HIV)-infected and high-risk women followed-up in the HIV Epidemiology Research Study (HERS) from 1993 through 1999. The rates of hospitalization and ER visits were measured as a function of recent or current PI use, age, race, transmission risk category, HERS site, baseline CD4 cell count, and baseline virus load; the PI effect was estimated separately by baseline CD4 cell count. In the HERS, PI use was strongly associated with lower rates of ER visits and hospitalizations for patients with baseline CD4 cell counts of <200 cells/mL (for hospitalizations: Rate ratio [RR], 0.54; 95% confidence interval [CI], 0.33-0.89; for ER visits: RR, 0.38; 95% CI, 0.24-0.61). Other factors associated with increased hospitalization and ER use included history of injection drug use, low CD4 cell counts, and high virus loads.

AB - The impact of protease inhibitors (PIs) on emergency department (i.e., emergency room [ER]) visits and hospitalizations was examined among a cohort of human immunodeficiency virus (HIV)-infected and high-risk women followed-up in the HIV Epidemiology Research Study (HERS) from 1993 through 1999. The rates of hospitalization and ER visits were measured as a function of recent or current PI use, age, race, transmission risk category, HERS site, baseline CD4 cell count, and baseline virus load; the PI effect was estimated separately by baseline CD4 cell count. In the HERS, PI use was strongly associated with lower rates of ER visits and hospitalizations for patients with baseline CD4 cell counts of <200 cells/mL (for hospitalizations: Rate ratio [RR], 0.54; 95% confidence interval [CI], 0.33-0.89; for ER visits: RR, 0.38; 95% CI, 0.24-0.61). Other factors associated with increased hospitalization and ER use included history of injection drug use, low CD4 cell counts, and high virus loads.

UR - http://www.scopus.com/inward/record.url?scp=0035893108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035893108&partnerID=8YFLogxK

U2 - 10.1086/323978

DO - 10.1086/323978

M3 - Article

C2 - 11700576

AN - SCOPUS:0035893108

VL - 33

SP - 2055

EP - 2060

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 12

ER -